Elgin Medical Center,pa Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 209 E 2nd St, Elgin, TX 78621 Phone: 512-285-3315 Fax: 512-281-2872 |
Serve All Medical Elgin Pllc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 706 W 11th St, Elgin, TX 78621 Phone: 512-229-3093 |
Ascension Seton Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 200 Roy Rivers Rd, Elgin, TX 78621 Phone: 512-237-5777 |
Family Health Center In Elgin Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 711 W 10th St., Elgin, TX 78621 Phone: 512-229-3334 |
Healing Branches Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 113 Four Star Dr, Elgin, TX 78621 Phone: 512-213-2366 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.
An interdisciplinary research team led by The University of Texas Medical Branch at Galveston reports a new breakthrough in countering the deadly effects of radiation exposure. A single injection of a regenerative peptide was shown to significantly increase survival in mice when given 24 hours after nuclear radiation exposure.
A Bloomberg poll conducted Dec. 3-7 found, on health care, "about half of poll respondents saying they disapprove of the plans in Congress to overhaul the system. Sixty-two percent of Americans say they are mostly pessimistic they would benefit from [a health-care bill Congress may pass.] The youngest Americans are more optimistic, with 47 percent of those under 35 saying they would benefit."
Researchers have identified a combination of biological markers in patients with dengue that could predict whether they go on to develop moderate to severe disease, according to a study published today in eLife.
› Verified 8 days ago